Journal profile · PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-INFECTIOUS DISEASES
Travel Medicine and Infectious Disease
ISSN 1477-8939 · eISSN 1873-0442 · Elsevier USA · ENGLAND · Founded 2003
Travel Medicine and Infectious Disease: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.53; fully open access; APC about USD 3,710; median 98 days to acceptance (94 articles, last 24 months); community-reported acceptance: fairly easy; 150 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Travel Medicine and Infectious Disease is published by Elsevier USA and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Travel-related health issues, Mosquito-borne diseases and control and Malaria Research and Control, together about 38.3% of its articles. Its main subfields are Public Health, Environmental and Occupational Health and Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Travel Medicine and Infectious Disease is dedicated to articles regarding infectious disease in the context of travel medicine.Travel Medicine and Infectious Disease aims to publish cutting edge papers and offers a fast peer-review process with early online publication of accepted manuscripts. It publishes articles on epidemiology and surveillance of travel-related illness, prevention and treatment of travel associated infections.Submissions on areas of controversy and debate in travel medicine particularly where this may inform guidelines and policy pertinent to travel medicine and the prevention of infectious disease are particularly welcomed.The journal publishes topics including:• Malaria prevention and treatment • Travellers' diarrhoea • Infections associated with mass gatherings • Migration related infections • Vaccines and vaccine preventable disease • Global policy regulations for disease prevention and control • Practical clinical issues for travel and tropical medicine practitioners
From the journal's Aims & Scope
Research area (LetPub): PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-INFECTIOUS DISEASES
Editorial board by country: 6 in mainland China (about 13%); most named United States 7, Mainland China 6, Canada 5, United Kingdom 4, Switzerland 3 (46 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Travel-related health issuesMedicine19.7%
- Mosquito-borne diseases and controlMedicine10.8%
- Malaria Research and ControlMedicine7.9%
- Viral Infections and VectorsMedicine5.9%
- COVID-19 epidemiological studiesMathematics5.6%
- Parasites and Host InteractionsImmunology and Microbiology5%
- Viral Infections and Outbreaks ResearchMedicine3.7%
- Zoonotic diseases and public healthMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.53LetPub ·
- Impact factor (publisher)
- 5.6Publisher website ·
- Impact factor (publisher) 2024
- 5.6Publisher website ·
- CiteScore 2026-06
- 8.8LetPub ·
- CiteScore (publisher)
- 8.8Publisher website ·
- CiteScore (publisher) 2024
- 8.8Publisher website ·
- SJR 2026-06
- 1.08LetPub ·
- SNIP 2026-06
- 1.38LetPub ·
- h-index
- 37LetPub ·
- h-index
- 98OpenAlex ·
- i10-index
- 1,257OpenAlex ·
- 2-year mean citedness
- 3.88OpenAlex ·
- Self-citation rate
- 5.4%LetPub ·
- Share of gold OA articles
- 99.22%LetPub ·
Volume
- Articles per year
- 121LetPub ·
Articles by year OpenAlex count · 2,939 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 70 | 70 | 40 |
| 2025 | 150 | 150 | 545 |
| 2024 | 107 | 107 | 683 |
| 2023 | 144 | 144 | 1,571 |
| 2022 | 236 | 173 | 3,861 |
| 2021 | 237 | 151 | 3,420 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
98 daysMedian, submission to acceptance · P25–P75 66 days – 150 days
- Acceptance to online
- median 2 days (94 articles)
- Submission to online
- median 100 days
- Sample
- 94 articles with submission and acceptance dates (256 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 40 daysPublisher website ·
- Submission to acceptance
- 76 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,710 / EUR 3,470 / GBP 2,970 / JPY 460,150 | — | — | |
| Publisher website | USD 3,780 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteArticle types accepted20, with length limits
- book reviewOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …Length not stated
- book reviewsBook Reviews - Submission of book reviews of up to 450 words. It may include references (no more than 5). No abstract, figures or tables should be included. The…Length not stated
- brief reportOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …main text ≤ 2,000 words
- brief reportsBrief Reports (presenting research data, case reports, or case series) should be between 1,000 and 2,000 words in length. It should contain a structured abstrac…Length not stated
- case reportOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …Length not stated
- commentariesCommentaries (presenting other topics different to research data) should between 1,000 - 2,000 words in length, with no more than 15 references. It may contain …Length not stated
- commentaryOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …main text ≤ 2,000 words
- correspondenceOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …Length not stated
- correspondence (letter)Correspondence (Letter) should be up to 900 words in length, with no more than seven references, and a maximum of 1 figure and 1 table. No abstract should be in…Length not stated
- diagnostic challengeDiagnostic Challenge - brief text of up to 300 words and if applicable a photograph of a highly relevant clinical case. No references or abstract should be incl…Length not stated
- editorialOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …Length not stated
- editorialsEditorials - Submission of Editorials is reserved for members of the Editorial Board. Submission of Editorials without consultation with the Editor-in-Chief wou…Length not stated
- letterOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …Length not stated
- meta-analysisOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …Length not stated
- original articleOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …main text ≤ 5,000 words
- original articlesOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Length not stated
- reviewOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …Length not stated
- review articleOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …main text ≤ 8,000 words
- review articlesReview articles should be between 3,000 and 8,000 words in length, with at least 40 cited references. It should contain a structured abstract of 200-250 words.Length not stated
- systematic reviewOriginal articles should be between 2,500 and 5,000 words in length. It should contain a structured abstract of 200-250 words.Review articles should be between …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Corresponding author: single corresponding author must be appointed. Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethics in publishing: follow Elsevier's Publishing Ethics Policy. Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Peer review process: single anonymized review process. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed in line with Elsevier's article sharing policy. Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier USA
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2003
- ISSN
- 1477-8939
- Electronic ISSN
- 1873-0442
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Travel Medicine and Infectious Disease
What CAS zone is Travel Medicine and Infectious Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Travel Medicine and Infectious Disease is in Zone 3 of Medicine, and in Zone 3 of the minor category Infectious Diseases / Public, Environmental & Occupational Health. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Travel Medicine and Infectious Disease?
The latest impact factor listed by LetPub is 5.53; CiteScore 8.8, h-index 98.
How long does peer review take at Travel Medicine and Infectious Disease?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 66–150 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Travel Medicine and Infectious Disease based?
Of the 46 board members whose country the journal's board page names, 6 (about 13%) are in mainland China; the countries named most often are United States (7), Mainland China (6) and Canada (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Travel Medicine and Infectious Disease?
According to LetPub and DOAJ records, Travel Medicine and Infectious Disease is indexed in SCIE, Scopus and DOAJ.
Is Travel Medicine and Infectious Disease open access, and what is the APC?
Travel Medicine and Infectious Disease is a fully open-access journal. APC about USD 3,710.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .